✦ LIBER ✦

Panitumumab with Irinotecan/Leucovorin/5-Fluorouracil for First-Line Treatment of Metastatic Colorectal Cancer

✍ Scribed by Jordan Berlin; James Posey; Simon Tchekmedyian; Eddie Hu; David Chan; Imtiaz Malik; Liqiang Yang; Rafael G. Amado; J. Randolph Hecht

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First-line panitumumab plus irinotecan/5

✍ Claus-Henning Köhne; Ralf Hofheinz; Laurent Mineur; Henry Letocha; Richard Greil 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 584 KB

Postmarketing Re-Evaluation of Irinoteca

✍ Isagani M. Chico; Richard Pazdur 📂 Article 📅 2002 🏛 CIG Media Group, LP. 🌐 English ⚖ 59 KB

Combining bevacizumab and panitumumab wi

✍ Liang, Hong-Liang; Hu, Ai-Ping; Li, Sen-Lin; Liu, Ji-Yong 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 195 KB

Recommendation for Irinotecan, 5-Fluorou

✍ Maxine D. Fisher; Leonard Saltz; Richard Goldberg; Richard Schilsky 📂 Article 📅 2001 🏛 CIG Media Group, LP. 🌐 English ⚖ 92 KB

Phase II Trial of Oxaliplatin/Irinotecan

✍ Robert R. McWilliams; Matthew P. Goetz; Bruce W. Morlan; Muhammad Salim; Kendrit 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 135 KB

Irinotecan plus fluorouracil: first-line

📂 Article 📅 2000 🏛 Adis International Limited (now part of Wolters Kl ⚖ 139 KB